Skip to main content
Top
Published in:

Open Access 18-12-2024 | Hyperkalemia | Case Report

Unravelling a mystery of hypokalemic hypertension- a rare case report of a reninoma

Authors: N.S.W Pathirana, P Dissanayake, S Pathmanathan, M.R Sumanatilleke, M.D.U Eranthaka, D.A Herath, T.M Samarasinghe, A.D.P Athukorala

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

Reninoma is a rare cause of secondary hypertension, which can be cured with surgery if identified early before any target organ damage occurs. It leads to hypokalaemia and hypertension and typically responds well to treatment with renin–angiotensin–aldosterone system blockers. However, confirmation of the diagnosis and the localisation of this rare culprit lesion can be challenging.

Case presentation

We describe a case of young-onset hypertension in a 19-year-old girl due to a reninoma. She had resistant hypertension with marked hypokalaemia, which required exceedingly high doses of potassium supplements. Biochemical Investigations revealed secondary hyperaldosteronism. Thus, she underwent a renal angiogram to exclude a renovascular cause for her hypertension. While the renal artery anatomy was normal, there was an exophytic renal lesion in the lower pole of the left kidney. Hence, the diagnosis of a reninoma was suspected. She underwent renal vein sampling to confirm the functionality of the detected tumour, but the results were inconclusive. After a multidisciplinary discussion, based on the clinical evidence, the renal lesion was thought to be a reninoma and a partial nephrectomy was done, removing the lesion. Immediately following resection, her blood pressure and potassium normalised without further drug treatment, and the resected lesion was later confirmed to be a reninoma by histopathological examination.

Conclusion

In young people with hypokalemic hypertension, reninoma should be considered when the more common causes are excluded since prompt treatment with excision of the culprit lesion can cure hypertension and prevent associated morbidity and mortality.
Appendix
Available only for authorised users
Literature
2.
go back to reference Jeemon P, Séverin T, Amodeo C, Balabanova D, Campbell NRC, Gaita D, Kario K, Khan T, Melifonwu R, Moran A, Ogola E, Ordunez P, Perel P, Piñeiro D, Pinto FJ, Schutte AE, Wyss FS, Yan LL, Poulter NR, Prabhakaran D. World Heart Federation Roadmap for Hypertension – A 2021 Update. Glob Heart n.d.;16:63. https://doi.org/10.5334/gh.1066. Jeemon P, Séverin T, Amodeo C, Balabanova D, Campbell NRC, Gaita D, Kario K, Khan T, Melifonwu R, Moran A, Ogola E, Ordunez P, Perel P, Piñeiro D, Pinto FJ, Schutte AE, Wyss FS, Yan LL, Poulter NR, Prabhakaran D. World Heart Federation Roadmap for Hypertension – A 2021 Update. Glob Heart n.d.;16:63. https://​doi.​org/​10.​5334/​gh.​1066.
3.
go back to reference Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro M-C, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin Y-H, Fallo F, Widimsky J. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗. J Hypertens. 2020;38:1919–28. https://doi.org/10.1097/HJH.0000000000002510.CrossRefPubMed Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro M-C, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin Y-H, Fallo F, Widimsky J. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗. J Hypertens. 2020;38:1919–28. https://​doi.​org/​10.​1097/​HJH.​0000000000002510​.CrossRefPubMed
8.
go back to reference Liu K, Wang B, Ma X, Li H, Zhang Y, Li J, Yao Y, Tang L, Xuan Y, Guo A, Zhang X. Minimally invasive surgery-based multidisciplinary clinical management of reninoma: a single-center study. Med Sci Monit 2019;25:1600–10. https://doi.org/10.12659/MSM.913826. Liu K, Wang B, Ma X, Li H, Zhang Y, Li J, Yao Y, Tang L, Xuan Y, Guo A, Zhang X. Minimally invasive surgery-based multidisciplinary clinical management of reninoma: a single-center study. Med Sci Monit 2019;25:1600–10. https://​doi.​org/​10.​12659/​MSM.​913826.
14.
19.
go back to reference Conn JW. Primary Reninism, A Surgically Curable Form of Hypertension. In: Frick P, Harnack G-A, Martini GA, Prader A, Schoen R, Wolff HP, editors. Ergebnisse der Inneren Medizin und Kinderheilkunde, Berlin, Heidelberg: Springer Berlin Heidelberg; 1974, p. 23–44. https://doi.org/10.1007/978-3-642-65746-7_2. Conn JW. Primary Reninism, A Surgically Curable Form of Hypertension. In: Frick P, Harnack G-A, Martini GA, Prader A, Schoen R, Wolff HP, editors. Ergebnisse der Inneren Medizin und Kinderheilkunde, Berlin, Heidelberg: Springer Berlin Heidelberg; 1974, p. 23–44. https://​doi.​org/​10.​1007/​978-3-642-65746-7_​2.
Metadata
Title
Unravelling a mystery of hypokalemic hypertension- a rare case report of a reninoma
Authors
N.S.W Pathirana
P Dissanayake
S Pathmanathan
M.R Sumanatilleke
M.D.U Eranthaka
D.A Herath
T.M Samarasinghe
A.D.P Athukorala
Publication date
18-12-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01804-0

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more